Abstract:Mutations in the large gene of clotting factor VIII (FVIII) are the most common events leading to severe human bleeding disorder. The high proportion of de novo mutations observed in this gene raises the possibility that a significant proportion of such mutations does not derive from a single germ cell but instead should be attributed to a germline or somatic mosaic originating from a mutation during early embryogenesis. The present study explores this hypothesis by using allele-specific PCR to analyze 61 fami… Show more
“…These include ornithine transcarbamylase deficiency, 17 Duchenne muscular dystrophy, 18 and hemophilia A. 19 Although it is not clear whether the single-gene mutation occurred as a postzygotic event or at the halfchromatid stage, before fertilisation, 20 somatic mosaicism should be considered when an X-linked dominant disease is observed in a male.…”
Rett syndrome is a severe neurodevelopmental disorder that arises from mutations in the X-linked MECP2 gene. It is almost exclusively seen in girls due to the predominant occurrence of the mutations on the paternal X-chromosome, and also the early postnatal lethal effect of the disease causing mutations in hemizygous boys. We identified a boy with features of classic Rett syndrome who is mosaic for the truncating MECP2 mutation R270X. Chromosome analysis showed normal karyotype. These results indicate that a MECP2 mutation associated with Rett syndrome in females could lead to a similar phenotype in males as a result of somatic mosaicism.
“…These include ornithine transcarbamylase deficiency, 17 Duchenne muscular dystrophy, 18 and hemophilia A. 19 Although it is not clear whether the single-gene mutation occurred as a postzygotic event or at the halfchromatid stage, before fertilisation, 20 somatic mosaicism should be considered when an X-linked dominant disease is observed in a male.…”
Rett syndrome is a severe neurodevelopmental disorder that arises from mutations in the X-linked MECP2 gene. It is almost exclusively seen in girls due to the predominant occurrence of the mutations on the paternal X-chromosome, and also the early postnatal lethal effect of the disease causing mutations in hemizygous boys. We identified a boy with features of classic Rett syndrome who is mosaic for the truncating MECP2 mutation R270X. Chromosome analysis showed normal karyotype. These results indicate that a MECP2 mutation associated with Rett syndrome in females could lead to a similar phenotype in males as a result of somatic mosaicism.
“…Partial or complete factor VIII gene deletions are found in about 5% of the families with severe hemophilia A, some of which include recombinations of repeated sequences of the line1 and Alu type (82,103). Family analysis shows that, similarly to the inversion with breakpoints in the 10 kb repeat in intron 22, the index patient carrying the rearrangement in Factor Viii gene is usually the first case in the family, born to a carrier mother (50), and that most (though not all) rearrangements occur in the male germline (10,64).…”
Section: Breaking May Be a New Beginning -But Of What Exactly?mentioning
“…This mechanism, if minor, remains underestimated by routine analysis and originates predominantly from females in the case of somatic mosaicism. This may represent a frequent event in hemophilia that must be considered in genetic counseling of isolated cases that mainly involve point mutations (Leuer et al, 2001). In the case of factor IX gene, a considerably lower mutation rate than for factor VIII has been reported (3.2 x 10 9 ) (Koeberl et al, 1990).…”
Section: Mutation-phenotype Correlation In Hemophilia 21 Origin Of Mmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.